*pmol/h/mg protein; †pmol/min/mg protein. | ||
ND, Not detectable; AMACR, α-methylacyl-CoA racemase. | ||
For methods see Ferdinandusse16. | ||
Patient | De novo plasmalogen biosynthesis: | Normal |
DHAP-AT activity: | Normal | |
Pristanic acid β- oxidation activity* | 284 | |
AMACR activity† | ND | |
Controls | Pristanic acid β- oxidation activity* | 1147 (SD 325) (n=30) |
AMACR activity† | 92 (SD 30) (n=11) |